GO:0001568 blood vessel development: Signaling Pathways, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0001568 blood vessel development describes the progression of a blood vessel from formation to mature structure, encompassing vasculogenesis, angiogenesis, and vessel maturation.
• Endothelial cells are the primary building blocks, but pericytes, smooth muscle cells, and extracellular matrix components are essential for vessel stabilization and function.
• Key signaling pathways include VEGF, Notch, angiopoietin-Tie, and TGF-beta, which coordinate sprouting, guidance, and remodeling.
• Human blood vessel organoids have emerged as powerful models to study development and disease, including diabetic vasculopathy.
• Dysregulated blood vessel development underlies cancer, diabetic retinopathy, and skeletal disorders, making it a major therapeutic target.
• CRISPR-based knockout, knock-in, and overexpression models enable causal dissection of genes controlling vessel development.
Description
Blood vessel development is a fundamental biological process that ensures the formation and maturation of the vascular network, which is required for oxygen and nutrient delivery to all tissues. This process, annotated as GO:0001568, encompasses the initial assembly of endothelial cells into primitive vessels (vasculogenesis), the sprouting and remodeling of new vessels from existing ones (angiogenesis), and the stabilization and maturation of the vessel wall. Understanding blood vessel development is critical because its dysregulation contributes to a wide range of pathologies, including cancer, diabetic vasculopathy, and skeletal disorders. Recent advances in human blood vessel organoids have provided a tractable model to study the molecular and cellular mechanisms of this process in vitro. This article integrates authoritative QuickGO annotation with real PubMed literature to provide a research-grade overview of blood vessel development, its key genes, regulatory mechanisms, and experimental approaches for investigation.
blood vessel development At A Glance
| GO ID | GO:0001568 |
|---|---|
| GO term | blood vessel development |
| Ontology | biological_process |
| Synonym | none |
| Major function | Formation and maturation of blood vessels from initial assembly to mature structure |
| Key cell types | Endothelial cells, pericytes, vascular smooth muscle cells |
| Major signaling pathways | VEGF, Notch, Angiopoietin-Tie, TGF-beta |
| Related processes | Vasculogenesis, angiogenesis, arteriogenesis, vessel remodeling |
| Disease relevance | Cancer, diabetic vasculopathy, skeletal disorders, retinopathies |
What Is GO:0001568?
According to the Gene Ontology, GO:0001568 blood vessel development is defined as the process whose specific outcome is the progression of a blood vessel over time, from its formation to the mature structure. The blood vessel is the vasculature carrying blood. This biological process includes the specification, proliferation, migration, and differentiation of endothelial cells, as well as the recruitment of mural cells and the formation of a stable, functional vessel wall.
Why Is blood vessel development Important in Cell Biology?
Blood vessel development is essential for embryonic development, tissue homeostasis, and repair, as it establishes the circulatory network that supplies oxygen and nutrients while removing waste. Defects in this process lead to vascular malformations, ischemia, and impaired tissue regeneration, whereas excessive or aberrant vessel growth contributes to tumor progression and diabetic complications. Therefore, understanding the molecular and cellular mechanisms of blood vessel development is crucial for developing targeted therapies for a wide range of human diseases.
• Provides the vascular network required for embryonic organogenesis and postnatal tissue growth.
• Dysregulation causes diabetic vasculopathy, as modeled in human blood vessel organoids.
• Tumor angiogenesis is a hallmark of cancer and a major therapeutic target.
• Coupling of angiogenesis and osteogenesis in bone is mediated by specific vessel subtypes.
• Notch signaling in endothelial cells promotes both angiogenesis and osteogenesis.
• Blood vessel development is critical for skeletal muscle postnatal development and myonuclear positioning.
• Human blood vessel organoids enable disease modeling and drug discovery.
• VEGF and Notch pathways are key regulators that can be manipulated genetically.
• Understanding vessel development informs regenerative medicine and tissue engineering.
• CRISPR screens can identify novel regulators of endothelial cell behavior.
What Happens During blood vessel development?
Vasculogenesis and Endothelial Specification
In simple terms: This is the initial step where precursor cells become endothelial cells and form the first primitive blood vessels.
Vasculogenesis begins with the differentiation of mesodermal precursors into endothelial cells, which then coalesce to form a primary vascular plexus. This process is driven by signaling molecules such as VEGF and is essential for establishing the early circulatory system. In human blood vessel organoids, similar early stages of endothelial specification and network formation have been observed, providing a model to study these events.
Angiogenic Sprouting and Guidance
In simple terms: New blood vessels sprout from existing ones and are guided by chemical signals to reach oxygen-starved tissues.
Angiogenesis involves the activation of endothelial cells, degradation of the basement membrane, and sprouting of new vessels toward angiogenic stimuli such as VEGF. Tip cells lead the sprout, while stalk cells proliferate to elongate the vessel, a process regulated by Notch signaling. This step is critical for expanding the vascular network during development and in response to hypoxia.
Vessel Remodeling and Mural Cell Recruitment
In simple terms: The initially formed vessels are remodeled into a hierarchical network, and support cells are recruited to stabilize them.
After sprouting, vessels undergo remodeling, which involves pruning of excess branches and recruitment of pericytes and smooth muscle cells to form a mature vessel wall. Signaling through angiopoietin-Tie and TGF-beta pathways is essential for vessel stabilization and quiescence. In bone, specific vessel subtypes couple angiogenesis with osteogenesis, highlighting the importance of remodeling in tissue-specific contexts.
Vessel Maturation and Barrier Function
In simple terms: The final step is the maturation of vessels into functional units with a tight barrier that controls what passes between blood and tissues.
Maturation involves the formation of tight junctions between endothelial cells, deposition of extracellular matrix, and establishment of a functional blood-tissue barrier. This process is critical for organ homeostasis and is often disrupted in disease. Human blood vessel organoids have been used to model diabetic vasculopathy, where maturation and barrier function are impaired.
Integration with Tissue Development
In simple terms: Blood vessels develop in coordination with the tissues they supply, ensuring proper organ growth and function.
Blood vessel development is tightly coupled with the development of surrounding tissues, such as bone and skeletal muscle. For example, in bone, endothelial Notch activity promotes both angiogenesis and osteogenesis, demonstrating the interdependence of vascular and skeletal development. Similarly, during skeletal muscle postnatal development, blood vessel organization influences myonuclear positioning.
Key Genes Involved in GO:0001568 blood vessel development
The following genes and proteins are central to blood vessel development, as supported by the cited literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| VEGFA | Key angiogenic growth factor; promotes endothelial proliferation, migration, and survival | Target for anti-angiogenic therapy; studied in organoids and animal models |
| KDR (VEGFR2) | Primary receptor for VEGF; mediates angiogenic signaling | Knockout causes embryonic lethality due to lack of vasculature |
| NOTCH1 | Regulates tip/stalk cell specification and sprouting angiogenesis | Modulates vessel branching and osteogenesis |
| DLL4 | Notch ligand; controls endothelial sprouting and vessel density | Haploinsufficiency leads to excessive sprouting |
| ANGPT1 | Angiopoietin-1; stabilizes vessels and promotes mural cell recruitment | Knockout results in vessel destabilization |
| ANGPT2 | Angiopoietin-2; antagonizes ANGPT1, promotes vessel remodeling | Involved in sprouting and vascular regression |
| TEK (TIE2) | Receptor for angiopoietins; regulates vessel stabilization and quiescence | Mutations linked to vascular malformations |
| PDGFB | Recruits pericytes and smooth muscle cells to nascent vessels | Knockout leads to pericyte deficiency and vessel instability |
| TGFBR1 | Mediates TGF-beta signaling in endothelial cells; regulates vessel maturation | Involved in hereditary hemorrhagic telangiectasia |
| ENG | Endoglin; TGF-beta co-receptor; modulates angiogenesis | Mutations cause hereditary hemorrhagic telangiectasia |
| CDH5 (VE-cadherin) | Endothelial adherens junction protein; maintains vessel integrity | Essential for vascular barrier function |
| PECAM1 (CD31) | Endothelial cell adhesion molecule; marker of endothelial cells | Used for immunostaining and sorting |
| EPHB4 | Receptor tyrosine kinase; guides arteriovenous specification | Regulates vessel remodeling |
| NRP1 | Neuropilin-1; VEGF co-receptor; enhances angiogenic signaling | Modulates vessel guidance |
| HIF1A | Hypoxia-inducible factor; drives VEGF expression under hypoxia | Central to hypoxia-induced angiogenesis |
| CXCR4 | Chemokine receptor; promotes endothelial progenitor recruitment | Involved in vasculogenesis |
| WNT7A | Wnt ligand; regulates endothelial cell proliferation and vessel formation | Studied in bone angiogenesis |
How Is blood vessel development Regulated?
Blood vessel development is regulated by a complex interplay of signaling pathways, including VEGF, Notch, angiopoietin-Tie, TGF-beta, and Wnt. Hypoxia is a major physiological trigger, stabilizing HIF1A and inducing VEGF expression. Notch signaling modulates endothelial tip/stalk cell specification and vessel branching. Additionally, metabolic and mechanical cues influence vessel remodeling and maturation. In bone, endothelial Notch activity couples angiogenesis with osteogenesis, highlighting tissue-specific regulatory mechanisms.
blood vessel development and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| VEGFA | Tumor angiogenesis; diabetic retinopathy | Knockout or overexpression in endothelial cells; organoid models |
| NOTCH1 | Skeletal disorders; vascular malformations | Endothelial-specific knockout; Notch inhibitor treatment |
| ENG | Hereditary hemorrhagic telangiectasia | Knockout or point mutation in endothelial cells |
| TEK | Vascular malformations | Knock-in of patient mutations; organoid models |
| HIF1A | Ischemia; tumor angiogenesis | Conditional knockout; hypoxia studies |
Cancer and Tumor Angiogenesis
Tumors require a blood supply for growth and metastasis, and they often hijack normal angiogenic mechanisms to form new vessels. VEGF and Notch pathways are frequently upregulated in tumors, making them targets for anti-angiogenic therapies. Understanding blood vessel development is therefore critical for developing strategies to inhibit tumor angiogenesis.
Diabetic Vasculopathy
Diabetes leads to vascular complications, including retinopathy and nephropathy, which are characterized by aberrant angiogenesis and vessel dysfunction. Human blood vessel organoids have been used to model diabetic vasculopathy, revealing that high glucose and inflammatory cytokines induce basement membrane thickening and impaired vessel function. This model provides a platform for testing therapeutic interventions.
Skeletal Disorders and Bone Angiogenesis
Blood vessel development is essential for bone formation and repair, and specific vessel subtypes couple angiogenesis with osteogenesis. Endothelial Notch signaling promotes both angiogenesis and osteogenesis, and its disruption leads to skeletal defects. Targeting these pathways may offer therapeutic avenues for bone diseases.
Vascular Malformations
Mutations in genes such as ENG, ACVRL1, and TEK cause hereditary hemorrhagic telangiectasia and other vascular malformations, which are characterized by abnormal vessel development. Studying these genes in model systems helps elucidate the molecular basis of these disorders.
From blood vessel development-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X regulate endothelial sprouting? | Endothelial-specific knockout in mice or human organoids |
| Does a point mutation in gene Y cause vascular malformation? | Knock-in of the mutation in endothelial cells or organoids |
| Can overexpression of gene Z enhance angiogenesis? | Endothelial-specific overexpression in mice or organoids |
| What is the role of gene W in vessel maturation? | Tagged knock-in for lineage tracing or protein localization |
| Which genes are essential for blood vessel development? | Genome-wide CRISPR knockout screen in endothelial cells |
| How does gene V affect pericyte recruitment? | Co-culture of endothelial cells with pericytes in organoid models |
How to Study the blood vessel development Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Single-cell RNA-seq | Transcriptomic profiles of individual cells | Identify endothelial cell subtypes and states |
| Confocal microscopy | Morphology and protein localization | Visualize vessel sprouting and mural cell coverage |
| CRISPR knockout screen | Gene essentiality and function | Discover novel regulators of angiogenesis |
| Proteomics | Protein abundance and modifications | Map signaling pathways in endothelial cells |
| Organoid culture | 3D vessel formation and function | Model diabetic vasculopathy and drug testing |
| Lineage tracing | Cell fate and origin | Track endothelial progenitors during development |
| Flow cytometry | Cell surface marker expression | Isolate endothelial cells from tissues |
| Western blot | Protein expression and phosphorylation | Validate signaling changes in knockout models |
Single-Cell RNA Sequencing
Single-cell RNA sequencing allows profiling of endothelial and mural cell heterogeneity during blood vessel development, revealing distinct cell states and trajectories. This method has been applied to human blood vessel organoids to uncover fate transitions and state changes.
Imaging and Lineage Tracing
Confocal and light-sheet microscopy enable visualization of vessel sprouting, remodeling, and mural cell recruitment in vivo and in organoids. Lineage tracing using genetic reporters helps track the origin and fate of endothelial cells during development.
CRISPR Screens
Pooled CRISPR knockout screens in endothelial cells or organoids can identify novel regulators of blood vessel development. These screens are powerful for unbiased discovery of genes controlling proliferation, migration, and tube formation.
Proteomics and Phosphoproteomics
Mass spectrometry-based proteomics can quantify protein expression and post-translational modifications in endothelial cells under angiogenic stimuli, providing insights into signaling dynamics. This approach helps identify novel therapeutic targets.
How CRISPR Can Be Used to Study GO:0001568 blood vessel development
Knockout
CRISPR knockout of candidate genes in endothelial cells or organoids can determine whether they are required for blood vessel development. For example, knockout of VEGFA or its receptor KDR leads to severe vascular defects. Large-scale knockout screens have identified novel regulators of endothelial sprouting.
Point Mutation
Introducing disease-associated point mutations (e.g., in ENG or TEK) using CRISPR base editing or homology-directed repair allows modeling of vascular malformations and testing of genotype-phenotype relationships. Such models can reveal how specific mutations alter endothelial cell signaling and vessel formation.
Knock-in
Knock-in of reporter genes (e.g., GFP) or tags into endogenous loci enables lineage tracing and protein localization studies in blood vessel development. For instance, tagging CDH5 or PECAM1 allows visualization of endothelial cells in vivo and in organoids.
Overexpression
CRISPR activation (CRISPRa) or transgenic overexpression of pro-angiogenic factors such as VEGFA can enhance vessel growth and is useful for studying sufficiency and therapeutic potential. Overexpression models in organoids can mimic pathological angiogenesis.
How EDITGENE Supports blood vessel development Research
Researchers studying blood vessel development-related genes often need to determine whether a candidate gene is causally involved in endothelial cell behavior, vessel morphogenesis, or disease. EDITGENE provides a comprehensive suite of CRISPR-based services to accelerate this discovery, from gene knockout to precise point mutations and overexpression, all tailored to vascular biology.
Contact EDITGENE today to design your custom CRISPR model for blood vessel development research.
Frequently Asked Questions About blood vessel development
What is GO:0001568 blood vessel development?
GO:0001568 is a Gene Ontology biological process term defined as the progression of a blood vessel over time, from its formation to the mature structure.
What genes are involved in blood vessel development?
Key genes include VEGFA, KDR, NOTCH1, DLL4, ANGPT1, ANGPT2, TEK, PDGFB, TGFBR1, ENG, CDH5, PECAM1, EPHB4, NRP1, HIF1A, CXCR4, and WNT7A, among others.
What are the main stages of blood vessel development?
The main stages are vasculogenesis, angiogenic sprouting, vessel remodeling and mural cell recruitment, and vessel maturation.
How is blood vessel development regulated?
It is regulated by signaling pathways such as VEGF, Notch, angiopoietin-Tie, TGF-beta, and Wnt, as well as hypoxia and mechanical cues.
What diseases are associated with abnormal blood vessel development?
Diseases include cancer, diabetic vasculopathy, skeletal disorders, and vascular malformations such as hereditary hemorrhagic telangiectasia.
What are human blood vessel organoids?
Human blood vessel organoids are 3D in vitro models derived from stem cells that self-assemble into vascular structures and are used to study development and disease.
How can CRISPR be used to study blood vessel development?
CRISPR can create knockout, point mutation, knock-in, and overexpression models in endothelial cells or organoids to test gene function in vessel formation.
What is the role of Notch signaling in blood vessel development?
Notch signaling regulates endothelial tip/stalk cell specification, sprouting angiogenesis, and couples angiogenesis with osteogenesis in bone.
What is diabetic vasculopathy?
Diabetic vasculopathy is a complication of diabetes characterized by impaired blood vessel function and structure, which can be modeled using human blood vessel organoids.
How does blood vessel development relate to bone formation?
Specific vessel subtypes in bone couple angiogenesis with osteogenesis, and endothelial Notch activity promotes both processes.
Conclusion
Blood vessel development (GO:0001568) is a complex, multi-step process essential for embryonic development and tissue homeostasis. Dysregulation of this process contributes to major human diseases, including cancer, diabetic vasculopathy, and skeletal disorders. Recent advances in human blood vessel organoids and CRISPR-based genetic tools have greatly enhanced our ability to dissect the molecular mechanisms governing vessel formation and maturation. Continued research in this field promises to yield new therapeutic strategies for vascular and related diseases.
References
- 1. Nikolova MT et al.. 2025. Fate and state transitions during human blood vessel organoid development.. Cell 188(12):3329-3348.e31 PMID: 40250419
- 2. Wimmer RA et al.. 2019. Human blood vessel organoids as a model of diabetic vasculopathy.. Nature 565(7740):505-510 PMID: 30651639
- 3. Carmeliet P et al.. 2011. Molecular mechanisms and clinical applications of angiogenesis.. Nature 473(7347):298-307 PMID: 21593862
- 4. Sequeira C et al.. 2024. Myonuclear position and blood vessel organization during skeletal muscle postnatal development.. Development 151(19) PMID: 39289869
- 5. Cleaver O. 2004. Blood vessel signals during development and beyond.. Curr Top Dev Biol 62:1-36 PMID: 15522737
- 6. Kusumbe AP et al.. 2014. Coupling of angiogenesis and osteogenesis by a specific vessel subtype in bone.. Nature 507(7492):323-328 PMID: 24646994
- 7. Senger DR et al.. 2011. Angiogenesis.. Cold Spring Harb Perspect Biol 3(8):a005090 PMID: 21807843
- 8. Ramasamy SK et al.. 2014. Endothelial Notch activity promotes angiogenesis and osteogenesis in bone.. Nature 507(7492):376-380 PMID: 24647000
